| 0 (0%) | 09-27 09:32 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 9.08 | 1-year : | 10.61 |
| Resists | First : | 7.78 | Second : | 9.08 |
| Pivot price | 7.11 |
|||
| Supports | First : | 7.14 | Second : | 6.75 |
| MAs | MA(5) : | 7.34 |
MA(20) : | 7.12 |
| MA(100) : | 7.73  |
MA(250) : | 12.3 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 76.9 |
D(3) : | 69.7 |
| RSI | RSI(14): 54.1 |
|||
| 52-week | High : | 28.67 | Low : | 6.09 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ BCYC ] has closed below upper band by 17.0%. Bollinger Bands are 37.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 7.54 - 7.59 | 7.59 - 7.62 |
| Low: | 7.27 - 7.33 | 7.33 - 7.37 |
| Close: | 7.32 - 7.41 | 7.41 - 7.47 |
Wed, 24 Sep 2025
Bicycle Therapeutics (NASDAQ:BCYC) Trading Up 7.8% - Here's Why - MarketBeat
Sun, 21 Sep 2025
126,062 Shares in Bicycle Therapeutics PLC Sponsored ADR $BCYC Acquired by Acadian Asset Management LLC - MarketBeat
Mon, 08 Sep 2025
Bicycle Therapeutics Expands Board with New Appointments - MSN
Mon, 08 Sep 2025
Analysts Positive on Bicycle Therapeutics (BCYC) After Q2 Results - Yahoo Finance
Mon, 18 Aug 2025
Analysts Just Slashed Their Bicycle Therapeutics plc (NASDAQ:BCYC) EPS Numbers - simplywall.st
Mon, 04 Aug 2025
BCYC Mountain Biking Season Launches at the Phoenixville XC Tree Tangle - Bicycle Coalition of Greater Philadelphia
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 50 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 1.3 (%) |
| Shares Short | 1,660 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -2.8111e+008 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -2 % |
| Return on Assets (ttm) | 965.8 % |
| Return on Equity (ttm) | -19.1 % |
| Qtrly Rev. Growth | 1.928e+007 % |
| Gross Profit (p.s.) | -48.8 |
| Sales Per Share | -22.29 |
| EBITDA (p.s.) | -1.48121e+008 |
| Qtrly Earnings Growth | -3.6 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -208 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.34 |
| Price to Cash Flow | 1.08 |
| Dividend | 0 |
| Forward Dividend | 1.59e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|